GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neovasc Inc (NAS:NVCN) » Definitions » Sale Of Business

Neovasc (Neovasc) Sale Of Business : $0.00 Mil (TTM As of Dec. 2022)


View and export this data going back to 2008. Start your Free Trial

What is Neovasc Sale Of Business?

Neovasc's sale of business for the three months ended in Dec. 2022 was $0.00 Mil. It means Neovasc gained $0.00 Mil from selling business. Neovasc's sale of business for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Sep. 2022 ), Neovasc gained the same money from selling business in Dec. 2022 ($0.00 Mil).

Neovasc Sale Of Business Historical Data

The historical data trend for Neovasc's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovasc Sale Of Business Chart

Neovasc Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neovasc Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neovasc Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neovasc Sale Of Business Related Terms

Thank you for viewing the detailed overview of Neovasc's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Neovasc (Neovasc) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neovasc Inc (NAS:NVCN) » Definitions » Sale Of Business
Comparable Companies
BSGM OSA AXDX SRTS TBIO SONX ELMD XTNT HYPR EAR ABT MDT SYK BSX SZSE:300760 EW DXCM ZBH ALGN PODD
Traded in Other Exchanges
N/A
Address
13562 Maycrest Way, Suite 5138, Richmond, BC, CAN, V6V 2J7
Website
https://www.neovasc.com
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.